On March 1, 2023, Inclusive Capital, which took a stake in Bayer earlier this year, are trying to force management to break up the company, which claiming one victory: the appointment of an outside candidate, Bill Anderson, to replace former CEO Werner Baumann, intends to split the Company into at least two parts: agribusiness and healthcare.
Market Closed -
Other stock markets
|
After market 20:53:58 | |||
25.98 EUR | -0.63% |
|
25.98 | 0.00% |
08:34pm | Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia | RE |
05:03pm | Global markets live: Bayer, FedEx, Nvidia, KKR, Verizon... | ![]() |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.73% | 27.5B | |
+54.51% | 815B | |
+44.25% | 654B | |
-6.30% | 354B | |
+21.08% | 337B | |
+10.99% | 302B | |
+18.45% | 247B | |
+2.09% | 229B | |
+13.03% | 219B | |
+8.75% | 171B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Inclusive Capital Provides Information to the Shareholders